Sagittarius Life Science (3205) — Capital Reinvestment Ratio
Sagittarius Life Science (3205) has a Capital Reinvestment Ratio of 0.66x as of September 2025, meaning it reinvests 1% of its operating cash flow (NT$125.00K) in capital expenditures (NT$83.00K). See 3205 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sagittarius Life Science Capital Reinvestment Ratio (2015–2016)
This chart tracks Sagittarius Life Science's Capital Reinvestment Ratio across 2 annual periods. Check total reinvestment intensity of Sagittarius Life Science to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sagittarius Life Science (2015–2016)
Year-by-year Capital Reinvestment Ratio for Sagittarius Life Science from 2015 to 2016. For live market cap and broader valuation context, see 3205 market cap.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.05x | NT$360.37 Million | NT$19.76 Million | ▲ +342.3% |
| 2015 | 0.01x | NT$237.94 Million | NT$2.95 Million | — |